Reno CyberKnife Upgrades Their CyberKnife® Robotic Radiosurgery System

NEWPORT BEACH, Calif. – April 26, 2016 – Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced radiology, oncology and interventional services, announced today that one of their radiation therapy centers, Reno CyberKnife, has upgraded their CyberKnife Robotic Radiosurgery System. The decision to upgrade the technology at the center was part of Reno CyberKnife’s commitment to ensure patients are treated with the most advanced technology available.

The CyberKnife System was upgraded from the 8.5 version to the 10.5 version, with extra features added including the Lung Optimized Treatment (LOT) function, the IRIS II, MultiPlan V5.5 TPS, and Xsight Spine Prone.

The Lung Optimized Treatment package is a suite of software that provides a complete fiducial free clinical solution for most lung cancer patients. Because fiducial implantation is no longer required, CyberKnife radiosurgery with Lung Optimized Treatment offers a completely noninvasive option, which is particularly important for medically or surgically inoperable patients. It enables physicians with greater flexibility in delivering radiosurgery treatments to patients with lung cancer, the most common and deadly cancer worldwide.

“Our CyberKnife upgrade will add versatility to our options on how we treat our lung cancer patients, allowing us individualize and optimize patient care,” said Jonathan Tay M.D., Co-Medical Director at Reno CyberKnife.

The IRIS II is a feature that will help provide a better quality treatment, as well as shorten it. The IRIS II is a variable-aperture collimator which uses two offset banks of six prismatic tungsten leaves to form a blurred regular dodecagon field of variable size which eliminates the need for changing the fixed collimators. With the new IRIS II, the CyberKnife only needs to travel around the tumor in one trip and the IRIS II can change the field sizes as needed, allowing for a short and smooth treatment. In addition, this feature grants the clinical team the choice of as many as nine various sizes of radiation beams to treat a tumor, compared to up to three sizes using fixed collimators. The extra flexibly improves the quality of treatment plans, particularly for irregular-shaped tumors.

The MultiPlan Treatment Planning System enables the clinical team (physicist, radiation oncologist and surgeon, among others) to generate high quality CyberKnife treatment plans with a stronger computation power and a better optimization algorithm. Flexible and individualized treatment plans can be created quickly and intuitively, resulting in a fast and accurate treatment delivery for the patient. Other key features of the Multiplan is that it offers remote tools that allows the physician to remotely run the MultiPlan Treatment Planning System from any location, provide enhanced communication capabilities, and give CyberKnife centers the ability to collaborate and outreach to remote facilities and physicians.

The feature of this new version of CyberKnife that has the most impact on patients is the Xsight Spine Prone. The Xsight Spine Prone tracking system provides tracking of tumors in or near the spine, allowing patients to be treated in the prone position (lying with the chest down and back up). This is wonderful news because delivering radiation to a posterior target, such as tumors in or near the spine, with the patient in the supine position (lying face up) results in a high number of monitor units per beam, which could induce a high dose of radiation to the surrounding healthy tissue. Other patient benefits of the Xsight Spine Prone include its targeting accuracy (1.5 mm), it is a noninvasive method of delivering spine radiosurgery, it is faster with less complex treatments, and it provides an additional treatment option for those who are not candidates for surgery or conventional radiation therapy.

The dedicated radiation oncologists and clinical team at Reno CyberKnife consistently strive for excellence in quality patient care and are committed to providing the best solution for each patient’s needs. With the latest version of the CyberKnife Robotic Radiosurgery System, they are well on their way to better treatment options with which to treat patients and improve their quality of life.

Reno CyberKnife is located at 645 North Arlington Ave., Ste. 120, Reno, Nev. 89503. For more information, or to make an appointment, please visit or call (775) 348-9900.

About Alliance HealthCare Services

Alliance HealthCare Services (NASDAQ: AIQ) is a leading national provider of outsourced healthcare services to hospitals and providers. We also operate freestanding outpatient radiology, oncology and interventional services clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by hospitals or providers. Diagnostic radiology services are delivered through the Radiology Division (Alliance HealthCare Radiology), radiation oncology services are delivered through the Oncology Division (Alliance Oncology), and interventional and pain management services are delivered through the Interventional Services Division (Alliance HealthCare Interventional Partners). Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of December 31, 2015, Alliance operated 563 diagnostic radiology and radiation therapy systems, including 116 fixed-site radiology centers across the country; and 32 radiation therapy centers and SRS facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states, where approximately 2,430 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit


Photo: The CyberKnife Robotic Radiosurgery System at Reno CyberKnife.